13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2023-12-31 $4.96B
Positions 49
Showing 12 of 12 rows (filtered from 61)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 AKERO THERAPEUTICS INC $0 0 -273,002 -100.00% 0.31%
2 AMBRX BIOPHARMA INC $0 0 -31,735 -100.00% 0.01%
3 ARGENX SE $0 0 -16,765 -100.00% 0.18%
4 AXSOME THERAPEUTICS INC $0 0 -100,000 -100.00% 0.16%
5 BIOMARIN PHARMACEUTICAL INC $0 0 -114,042 -100.00% 0.23%
6 DAQO NEW ENERGY CORP $0 0 -2,037,000 -100.00% 1.38%
7 EXACT SCIENCES CORP $0 0 -197,894 -100.00% 0.30%
8 KINIKSA PHARMACEUTICALS LTD $0 0 -698,741 -100.00% 0.27%
9 ROIVANT SCIENCES LTD $0 0 -2,448,579 -100.00% 0.64%
10 SURROZEN INC $0 0 -384,573 -100.00% 0.00%
11 TESLA INC $0 0 -30,000 -100.00% 0.17%
12 THERMO FISHER SCIENTIFIC INC $0 0 -31,952 -100.00% 0.36%